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Case report
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Hepatic hydrothorax — complication
of end-stage hepatic cirrhosis
Abstract
A 62-year-old woman admitted to the hospital with dyspnoea, elevated body temperature, cough for two
days. Patient has been treated for alcoholic hepatic sclerosis for 12 years and hepatitis C infection for 5
years. The chest X-ray revealed hydrothorax of right pleura. Continuous drainage of the right pleura was
applied. In spite of intensive treatment effusion excuded 1000 ml/day making pleurodesis impossible, and
eventually pleuro-peritoneal shunt was performed. Shunt drainage however turned out to be insufficient to
evacuate the pleural fluid. The shunt was removed and continuous pleural drainage was reopen. Due to
subsequent disseminated intravascular coagulation, patient was treated with fresh frozen plasma, heparin,
blood and platelets. The clinical status alleviated, but patient still required chest tube because of the
refractory hydrothorax.
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Introduction
Cirrhosis is defined as the histological develop-
ment of regenerative nodules surrounded by fibrous
bands in response to chronic liver injury, which leads
to portal hypertension and end-stage liver disease
[1]. Patients with cirrhosis can aquire several pulmo-
nary conditions related to portal hypertension, in-
cluding hepatopulmonary syndrome, portopulmo-
nary hypertension, spontaneous bacterial empye-
ma, and hepatic hydrothorax [2]. The difficult-to-
manage hepatic hydrothorax is typically found in
advanced stages of cirrhosis [3].
Case report
A 62-year-old Caucasian woman was admitted
to the university hospital in Gdansk with dyspnea,
elevated body temperature (39∞C) and cough per-
sisting for two days. Patient had been treated for
alcoholic hepatic sclerosis for 12 years. During this
time she has been deteriorating gradually with sev-
eral severe exacerbations and oesophageal variceal
hemorrhages. Five years after the diagnosis of alco-
holic hepatic cirrhosis, hepatitis C infection was di-
agnosed. In spite of poor prognosis and severe clin-
ical course of the disease patient continued to use
alcohol.
Physical examination revealed decreased breath
sounds over the lower part of the right lung, crecip-
itations over the upper part of the right lung, ascites
and jaundice, body temperature was 39∞C. The chest
X-ray showed hydrothorax of the right pleura and
pneumonia of the right lung (Figure 1). CT examina-
tion of the chest showed large quantity of pleural
fluid and pneumonia. Laboratory abnormalities in-
cluded: elevated bilirubin, liver enzymes, ammonia
and increased CRP (Table 1).
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Table 1. Laboratory test results
Biochemical screen Full blood count  Urinalysis
Na [mEq/l] 138 HGB [g/dl] 6.9 Color Yellow
K [mEq/l] 3.1 RBC [T/L] 1,8 Specific gravity
[kg/l] 1.010
Glucose post prandial [mg/dl] 438 HCT (%) 19 Glucosa Neg
Creatinine [mg/dl] 1.59 MCV [fl] 110 Bilirubin  Neg
BUN [mg/dl] 41 MCH [pg] 39 Proteine Neg
AspAT [U/l] 38 MCHC [g/dl] 35 Red cell 4–10
AlAT [U/l] 18 PLT [G/l] 61 Leukocyte count Few
Total bilirubin [mg/dl] 3,8 WBC [G/l] 3.74
GGTP [U/L] 164 Neutrophilic
granulocytes (%) 77.4
LDH [U/L] 356 Lymphocytes (%) 8.8
Amonia [µmol/l] 137 Monocytes (%) 10,2
ALP [U/I] 134 Eosinophilic
 granulocytes (%) 3.2
Total protein Basophilic
 [g/l] 48 granulocytes (%) 0.31
Albumin [g/l] 15
CRP 31.9 Coagulation tests
Capilar blood gases Protrombin ratio (%) 69
pH 7,41 CA 125 U/ml 408.5 INR 1.54
pCO2 [mm Hg] 29,2 APTT [s] 44.8
pO2 [mm Hg] 54.3 Fibrynogen [g/l] 2.81
HCO3– [mmo I/L] 18.2 D-dimers 755
HCO3 std [mmo I/L] 19.9 AT III % 33.2
BEecf [mmo I/L] -5.6
BE (B) [mmo I/L] -5.3
SO2c (%) 89
Figure 1. Chest X-ray
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The diagnosis was right pleuropneumonia, he-
patic cirrhosis, hepatorenal syndrome.
Continuous drainage of the right pleura was ap-
plied as well as antibiotics (amoxycycline, metron-
idazole). Pleural fluid and blood cultures were nega-
tive. However Pseudomonas aeruginosa was found
in sputum thus the antibiotic was changed to ceftazi-
dime. The examination of fluid showed transduate,
amylase was normal, CA125 was insignificantly ele-
vated. In spite of intensive treatment effusuion ex-
cuded 1000 ml/day making pleurodesis impossible,
and eventually the pleuro-peritoneal shunt was per-
formed. Pleuroscopic examination of pleura showed
no abnormalities. The postoperative period was com-
plicated with renal, hepatic insufficiency and car-
diogenic shock. Shunt drainage turned out to be
insufficient to evacuate the pleural fluid, and even-
tually shunt was removed and the continuous pleu-
ral drainage with Heimlich valve was reopen. The
bacteriological examination of the pleural fluid re-
vealed Corynebacterium jejunium. Treatment with
vancomycin and albumin supplementation was in-
troduced. Subsequently disseminated intravascular
coagulation (DIC) occurred, and was treated with
fresh frozen plasma, heparin, blood and platelets.
The clinical status became alleviated, but patient
still required with chest tube because of refractory
hydrothorax.
Discussion
Liver transplantation remains the only curative
option for a selected group of patients, however
pharmacological treatments that could halt progres-
sion to decompensated cirrhosis are needed [1]. The
disease may lead eventualy to liver failure and may
become complicated with ascites.
Hepatic hydrothorax is a relatively uncommon
complication of end-stage liver insufficiency with an
estimated prevalence of 5–10%. The pathophysiolo-
gy includes the direct movement of ascetic fluid
from the peritoneal cavity into the pleural space
through diaphragmatic defects [4]. The effusion is
found most commonly in the right hemithorax, less
frequently on the left side and very rarely — bilater-
ally [4, 5]. The effusion is usually transudate. Hepat-
ic hydrothorax can accumulate slowly, but on rare
occasions patients present with acute tension hy-
drothorax which can fill the whole pleural cavity [6].
The first-line therapy includes sodium restriction and
administration of diuretics (spironolactone up to
400 mg/day and furosemide up to 160 mg/day).
Thoracocentesis is a simple and effective procedure
indicated in recurrent hydrothorax and for relief of
dyspnea. It is recommended to remove no more
than 2l at a time because there is a risk of re-expan-
sion pulmonary oedema or hypotension [7]. When
thoracocentesis is required every 2–3 weeks alterna-
tive strategies should be considered [4]. Chest tube
should be avoided as associated with complication
such as hypovolemic shock or empyema. Pleurode-
sis is not routinely recommended as well. Refractory
hydrothorax can be managed with transjugular in-
trahepatic portosystemic shunt (TIPS) in selected
cases [4]. Good response to TIPS placement is found
in 70–80% of patients. TIPS may help as a bridge to
liver transplantation [8]. For those patients that can-
not undergo TIPS placement, consideration for pleu-
rodesis or diaphragmatic repair by thoracoscopy
should be considered [4].
Our patient cannot undergo liver transplanta-
tion and TIPS, so chest tube was recommended for
pleurodesis. Although she was treated with diuret-
ics, albumin and pleuro-peritoneal shunt unfortu-
natelly the talc pleurodesis cannot be perform be-
couse of persistent drainage of pleural effusion.
Every third of all cirrhotic patients with hydrothorax
dies with chest tube still in the place. Failure to
remove the chest tube increases mortality in pa-
tients with increasing severity of liver disease [3].
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